CPRX Q1 2020 Earnings — Catalyst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

CPRXCatalyst Pharmaceuticals, Inc.

$3B

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$29M+134.1% YoY

Gross Profit

$25M85.8% margin

Operating Income

$11M36.7% margin

Net Income

$10M35.8% margin

EPS (Diluted)

$0.10

QoQ Revenue Growth

-3.3%

Cash Flow

Operating Cash Flow

$7M

Free Cash Flow

$7M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$118M

Total Liabilities

$18M

Stockholders' Equity

$100M

Cash & Equivalents

$102M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$29M	$12M	+134.1%
Gross Profit	$25M	$11M	+132.7%
Operating Income	$11M	-$987,769	+1183.2%
Net Income	$10M	-$644,503	+1717.7%